Celldex Therapeutics Inc Price Chart
Celldex Therapeutics Inc TCE2.MU Financial and Trading Overview
| Celldex Therapeutics Inc stock price | 37.8 EUR |
| Previous Close | 34.4 EUR |
| Open | 33.2 EUR |
| Bid | 33.6 EUR x 0 |
| Ask | 33.8 EUR x 0 |
| Day's Range | 33.2 - 33.2 EUR |
| 52 Week Range | 21.2 - 43.36 EUR |
| Volume | 55 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
TCE2.MU Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Celldex Therapeutics Inc Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 43.36 EUR |
| 52 Week Low | 21.2 EUR |
| 50-Day Moving Average | 30.49 EUR |
| 200-Day Moving Average | 34.62 EUR |
TCE2.MU Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Q&A For Celldex Therapeutics Inc Stock
What is a current TCE2.MU stock price?
Celldex Therapeutics Inc TCE2.MU stock price today per share is 37.8 EUR.
How to purchase Celldex Therapeutics Inc stock?
You can buy TCE2.MU shares on the Munich exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Celldex Therapeutics Inc?
The stock symbol or ticker of Celldex Therapeutics Inc is TCE2.MU.
How many shares does Celldex Therapeutics Inc have in circulation?
The max supply of Celldex Therapeutics Inc shares is 0.
What is Celldex Therapeutics Inc Price to Earnings Ratio (PE Ratio)?
Celldex Therapeutics Inc PE Ratio is now.
What was Celldex Therapeutics Inc earnings per share over the trailing 12 months (TTM)?
Celldex Therapeutics Inc EPS is 0 EUR over the trailing 12 months.